✉news WorldReligion first seen 15 h ago, last 15 h ago, peak #34
Falls Church biotech Retension Pharmaceuticals plans IPO
Original: Falls Church's Retension Pharmaceuticals plots IPO to advance hypertension drug
Retension Pharmaceuticals, a biotech company based in Falls Church, Virginia, is planning an initial public offering. Proceeds would be used to advance the company's hypertension drug candidate through development. The move would give the small drug developer access to public markets to fund late-stage testing of its treatment for high blood pressure, a condition affecting a large share of adults.
Why now: The IPO plan is newly reported and signals the company is seeking public funding for its drug pipeline.
Retension PharmaceuticalsFalls Church
Evidence
- Falls Church's Retension Pharmaceuticals plots IPO to advance hypertension drug · The Business Journals
API: https://socialmediatrends-api.osmike.com/v1/trends/1149002